Comparative evaluation of the QMAC-dRAST V2.0 system for rapid antibiotic susceptibility testing of Gram-negative blood culture isolates. 2020

Patrick Grohs, and Emilie Rondinaud, and Myriam Fourar, and Karama Rouis, and Jean-Luc Mainardi, and Isabelle Podglajen
Microbiology department, Georges Pompidou European Hospital, AP-HP-Centre Université de Paris, Université de Paris, Paris, France. Electronic address: patrick.grohs@aphp.fr.

To comparatively evaluate the performance of the rapid antimicrobial susceptibility testing (AST) system QMAC-dRAST V2.0 and of standard disk diffusion in agar, AST was performed directly from 100 positive blood culture bottles with Gram-negative bacilli. AST results provided by QMAC-dRAST showed 92.9% agreement with disk diffusion method results. Discrepancies observed between results obtained with QMAC-dRAST and disk diffusion method conducted to 10 very major errors (0.8%, S with QMAC-dRAST vs R with disk diffusion method), 40 major errors (3.2%, R vs S, respectively), 15 minor errors (1.2%, S vs I or I vs R, respectively) and 23 very minors errors (1.8%, I vs S or R vs I, respectively). For very major and major errors, in only 36% of the cases did the repeat QMAC-dRAST confirm the initial result, whereas a repeat AST using disk diffusion method confirmed the initial result in 92% of cases. AST results obtained using microdilution in liquid medium confirmed those obtained with QMAC-dRAST and disk diffusion method in 4% and 89%, respectively. Repeatability and reproducibility tests performed on QMAC-dRAST using reference strains showed 94% to 100% of R/S/I categorical agreement.

UI MeSH Term Description Entries
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071997 Blood Culture Test to determine the presence of blood infection (e.g. SEPSIS; BACTEREMIA). Blood Culture Test,Blood Culture Tests,Blood Cultures,Culture Test, Blood,Culture Tests, Blood,Culture, Blood,Cultures, Blood,Test, Blood Culture,Tests, Blood Culture
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D016470 Bacteremia The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion. Bacteremias
D052978 Disk Diffusion Antimicrobial Tests A method where a culturing surface inoculated with microbe is exposed to small disks containing known amounts of a chemical agent resulting in a zone of inhibition (usually in millimeters) of growth of the microbe corresponding to the susceptibility of the strain to the agent. Bauer-Kirby Disk-Diffusion Method,Epsilometer Test,Etest,Kirby-Bauer Disk-Diffusion Method,Bauer Kirby Disk Diffusion Method,Disk-Diffusion Method, Bauer-Kirby,Disk-Diffusion Method, Kirby-Bauer,Epsilometer Tests,Etests,Kirby Bauer Disk Diffusion Method,Test, Epsilometer,Tests, Epsilometer

Related Publications

Patrick Grohs, and Emilie Rondinaud, and Myriam Fourar, and Karama Rouis, and Jean-Luc Mainardi, and Isabelle Podglajen
May 2024, Journal of clinical laboratory analysis,
Patrick Grohs, and Emilie Rondinaud, and Myriam Fourar, and Karama Rouis, and Jean-Luc Mainardi, and Isabelle Podglajen
June 2022, Microorganisms,
Patrick Grohs, and Emilie Rondinaud, and Myriam Fourar, and Karama Rouis, and Jean-Luc Mainardi, and Isabelle Podglajen
August 2019, The Journal of antimicrobial chemotherapy,
Patrick Grohs, and Emilie Rondinaud, and Myriam Fourar, and Karama Rouis, and Jean-Luc Mainardi, and Isabelle Podglajen
March 2023, The Journal of antimicrobial chemotherapy,
Patrick Grohs, and Emilie Rondinaud, and Myriam Fourar, and Karama Rouis, and Jean-Luc Mainardi, and Isabelle Podglajen
November 1986, American journal of clinical pathology,
Patrick Grohs, and Emilie Rondinaud, and Myriam Fourar, and Karama Rouis, and Jean-Luc Mainardi, and Isabelle Podglajen
January 1984, Chemotherapy,
Patrick Grohs, and Emilie Rondinaud, and Myriam Fourar, and Karama Rouis, and Jean-Luc Mainardi, and Isabelle Podglajen
August 2017, Scientific reports,
Patrick Grohs, and Emilie Rondinaud, and Myriam Fourar, and Karama Rouis, and Jean-Luc Mainardi, and Isabelle Podglajen
January 2012, Diagnostic microbiology and infectious disease,
Patrick Grohs, and Emilie Rondinaud, and Myriam Fourar, and Karama Rouis, and Jean-Luc Mainardi, and Isabelle Podglajen
April 2023, The Journal of antimicrobial chemotherapy,
Patrick Grohs, and Emilie Rondinaud, and Myriam Fourar, and Karama Rouis, and Jean-Luc Mainardi, and Isabelle Podglajen
August 2001, Journal of clinical microbiology,
Copied contents to your clipboard!